UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Volltextzugriff (PDF)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002435

2021

Volltextzugriff (PDF)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Volltextzugriff (PDF)

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Journal of clinical oncology, 2008-02, Vol.26 (6), p.870-876

2008

Volltextzugriff (PDF)

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2457-2463

2008

Volltextzugriff (PDF)

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2014-01, Vol.32 (2), p.129-160

2014

Volltextzugriff (PDF)

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Journal of clinical oncology, 2008-02, Vol.26 (6), p.848-855

2008

Volltextzugriff (PDF)

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-03, Vol.38 (7), p.706-714

2020

Volltextzugriff (PDF)

Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer

Chest, 2003-01, Vol.123 (1), p.226S-243S

2003

Volltextzugriff (PDF)

Precision Medicine in Lung Cancer Treatment

Surgical oncology clinics of North America, 2020-01, Vol.29 (1), p.15-21

2020

Volltextzugriff (PDF)

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1660-1665

2015

Volltextzugriff (PDF)

Multidisciplinary Care of the Cancer Patient

Surgical oncology clinics of North America, 2013-04, Vol.22 (2), p.xiii-xiv

Masters, Gregory A., MD

2013

Volltextzugriff (PDF)

Phase II Trial of Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Trial 1597

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1550-1555

2003

Volltextzugriff (PDF)

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Clinical cancer research, 2017-10, Vol.23 (19), p.5711-5719

2017

Volltextzugriff (PDF)

Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer

Cancer medicine (Malden, MA), 2018-07, Vol.7 (7), p.2969-2973

2018

Volltextzugriff (PDF)

Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey

Cancer, 2022-07, Vol.128 (14), p.2817-2825

2022

Volltextzugriff (PDF)

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study

Journal of thoracic oncology, 2016-12, Vol.11 (12), p.2208-2217

2016

Volltextzugriff (PDF)

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Journal of clinical oncology, 2015-03, Vol.33 (7), p.786-809

2015

Volltextzugriff (PDF)

Multimodality Approach to Management of Stage III Non–Small Cell Lung Cancer

Surgical oncology clinics of North America, 2013-04, Vol.22 (2), p.319-328

2013

Volltextzugriff (PDF)

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.68-71

2021

Volltextzugriff (PDF)

Progress in lung cancer: ASCO 2015

Surgical oncology, 2015-12, Vol.24 (4), p.367-368

Masters, Gregory A

2015

Volltextzugriff (PDF)

A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113

Cancer, 2017-01, Vol.123 (2), p.303-311

2017

Volltextzugriff (PDF)

Intraoperative Sentinel Lymph Node Mapping in Non–Small-Cell Lung Cancer Improves Detection of Micrometastases

Journal of clinical oncology, 2002-04, Vol.20 (8), p.1984-1988

2002

Volltextzugriff (PDF)

Sex-associated differences in survival of patients undergoing resection for lung cancer

The Annals of thoracic surgery, 2000-01, Vol.69 (1), p.245-249

2000

Volltextzugriff (PDF)

Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538

JAMA network open, 2024-10, Vol.7 (10), p.e2440673

2024

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(250)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(155)
Humans
(123)
Oncology
(74)
Female
(63)
Male
(60)
Middle Aged
(49)
Aged
(47)
Adult
(44)
Biological And Medical Sciences
(39)
Lung Neoplasms - Drug Therapy
(39)
Lung Neoplasms - Pathology
(34)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(29)
Aged, 80 And Over
(28)
Carcinoma, Non-Small-Cell Lung - Pathology
(25)
Medical Sciences
(24)
Neoplasm Staging
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Neurosciences & Neurology
(21)
Treatment Outcome
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer

Precision Medicine in Lung Cancer Treatment

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Multidisciplinary Care of the Cancer Patient

Phase II Trial of Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Trial 1597

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer

Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Multimodality Approach to Management of Stage III Non–Small Cell Lung Cancer

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Progress in lung cancer: ASCO 2015

A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113

Intraoperative Sentinel Lymph Node Mapping in Non–Small-Cell Lung Cancer Improves Detection of Micrometastases

Sex-associated differences in survival of patients undergoing resection for lung cancer

Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538

Suchergebnisse filtern